MrSnapple, well done for being an investor with CUV, interesting...

MrSnapple, well done for being an investor with CUV, interesting time for you guys! Hey, one clarification, what do you mean by "I hope we have a chance of skipping the phase 3 trails and be approved by the FDA", are you talking about PAR? Do you mean MPS and the chance of a combined Phase 2/3 trial? It wouldnt be possible for PAR to skip a Phase 3 trial totally would it? I cant see that happening as OA for example isnt strictly a direct death causing disease (ruling out indirectly effect of current Opioid treatments etc). The only way I can figure out how we could 'skip' Phase 3 is if the TGA for example allow compassionate use (and perhaps the same equivalent body [FDA] in the US), but in any case we would still need to do a Phase 3 anyway albeit a reduced sample size and hopefully a fast tracked one.

Second question for you/others, what is involved to get European approval, am I correct in saying that CUV have been using their product over there for months now? Is the FDA/TGA equivalent process as rigorous there?